Kerala Ayurveda has informed that KAL reports 44% revenue growth in Q1 26 vs. PY (38% growth excluding Ayurvedagram Bali). Adjusted EBITDA* positive at Rs.6.4 Crs (+Rs.5.4 Crs. vs. PY) with continued investment in talent hiring, marketing and building infrastructure over the first quarter of 2026. KAL continues on its path to Double the growth rate in 2026 to 50% topline growth with investments in chosen drivers of growth - the Digital and Health service businesses powered by world class talent, marketing, technology and international expansion. Press release regarding the same enclosed.
The above information is a part of company’s filings submitted to BSE.
